Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Serotonin N-acetyltransferase: Mechanism and Inhibition

Author(s): Weiping Zheng and Philip A. Cole

Volume 9 , Issue 12 , 2002

Page: [1187 - 1199] Pages: 13

DOI: 10.2174/0929867023370013

Price: $65

Abstract

Serotonin N-acetyltransferase (arylalkylamine N-acetyltransferase, AANAT) catalyzes the rate-limiting step in the biosynthesis of the circadian hormone melatonin from serotonin. Although melatonin was identified 40 years ago, relatively little is known about its (patho)physiological roles, and a solid scientific foundation is still lacking for most therapeutic applications currently claimed for melatonin. The development of potent, specific, and cell permeable inhibitors for AANAT should constitute an important strategy to address these issues. These inhibitors are also potential therapeutics for various sleep / mood disorders. This review will focus on the efforts toward developing in vitro and in vivo AANAT inhibitors, including basic mechanistic studies on AANAT, which have played an important role in design.

Keywords: aanat, serotonin n-acefyltransferase, sleep disorder, mood disorder, aanat inhibitor


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy